KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Buildings (2016 - 2025)

Merck (MRK) has disclosed Buildings for 17 consecutive years, with $18.0 billion as the latest value for Q4 2025.

  • Quarterly Buildings rose 9.92% to $18.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.0 billion through Dec 2025, up 9.92% year-over-year, with the annual reading at $18.0 billion for FY2025, 9.92% up from the prior year.
  • Buildings for Q4 2025 was $18.0 billion at Merck, up from $16.4 billion in the prior quarter.
  • The five-year high for Buildings was $18.0 billion in Q4 2025, with the low at $12.5 billion in Q4 2021.
  • Average Buildings over 5 years is $15.0 billion, with a median of $15.0 billion recorded in 2023.
  • The sharpest move saw Buildings rose 4.43% in 2021, then rose 13.67% in 2023.
  • Over 5 years, Buildings stood at $12.5 billion in 2021, then grew by 5.08% to $13.2 billion in 2022, then increased by 13.67% to $15.0 billion in 2023, then increased by 9.31% to $16.4 billion in 2024, then increased by 9.92% to $18.0 billion in 2025.
  • According to Business Quant data, Buildings over the past three periods came in at $18.0 billion, $16.4 billion, and $15.0 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.